Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin.

Journal of the American College of Surgeons - 1 Mar 2002

Tabrizi Arash Rafii, Zehnbauer Barbara A, Borecki Ingrid B, McGrath Sean D, Buchman Timothy G, Freeman Bradley D

Abstract excerpt

BACKGROUND: Warfarin sodium (warfarin) is commonly prescribed in surgical practice. Warfarin use is complicated by an unpredictable dose response that may be due in part to genetically determined differences in metabolic capacity. To better understand the interaction between genotype and response to warfarin therapy, we determined the frequency and functional effects of polymorphisms of the predominant cytochrome...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P-450 CYP2C9

Share to Cytochrome P-450 Enzyme System

Share to Regression Analysis

Share to Steroid 16-alpha-Hydroxylase

Share to Steroid Hydroxylases

Share to Warfarin

Source

Identifiers

PMID: 11893129
DOI: 10.1016/s1072-7515(01)01163-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The frequency and effects of cytochrome P450 (CYP) 2C9 polymorphisms in patients receiving warfarin.PMID 11893129Read ↗

Frequency of CYP2C9 polymorphisms affecting warfarin metabolism in a large anticoagulant clinic cohort.Semantic proximity Read ↗

Cytochrome P450 polymorphisms are associated with reduced warfarin dose.Semantic proximity Read ↗

Relative impact of covariates in prescribing warfarin according to CYP2C9 genotype.Semantic proximity Read ↗

Warfarin and cytochrome P450 2C9 genotype: possible ethnic variation in warfarin sensitivity.Semantic proximity Read ↗

CYP2C9*8 is Prevalent Among African–Americans: Implications for Pharmacogenetic DosingSemantic proximity Read ↗

CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis.Semantic proximity Read ↗

Warfarin dosing and cytochrome P450 2C9 polymorphisms.Semantic proximity Read ↗

Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose.Semantic proximity Read ↗

Effect of polymorphisms in the cytochrome P450 CYP2C9 gene on warfarin anticoagulation.Semantic proximity Read ↗

Influence of <i>CYP2C9</i> Genotype on Warfarin Dose Among African–Americans and European–AmericansSemantic proximity Read ↗

Novel CYP2C9 genetic variants in Asian subjects and their influence on maintenance warfarin dose.Semantic proximity Read ↗

Genetic polymorphism of the human cytochrome P450 2C9 gene and its clinical significance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.